| pubmed-article:16950982 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16950982 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:16950982 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16950982 | lifeskim:mentions | umls-concept:C0002986 | lld:lifeskim |
| pubmed-article:16950982 | lifeskim:mentions | umls-concept:C0962517 | lld:lifeskim |
| pubmed-article:16950982 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16950982 | pubmed:dateCreated | 2006-9-4 | lld:pubmed |
| pubmed-article:16950982 | pubmed:abstractText | Fabry disease is an X-linked multisystem disorder. Enzyme-replacement therapy in adults has limited efficacy in treating major sequelae of advanced Fabry disease, such as kidney failure or stroke. This prompted a study of the safety and efficacy of enzyme replacement at an earlier stage of Fabry disease. | lld:pubmed |
| pubmed-article:16950982 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16950982 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16950982 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16950982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16950982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16950982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16950982 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16950982 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16950982 | pubmed:issn | 1098-4275 | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:SchiffmannRap... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:BradyRoscoe... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:SchlaggarBrad... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:BeckMichaelM | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:KampmannChris... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:RiesMarkusM | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:PastoresGrego... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:ClarkeJoe T... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:WhybraCathari... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:RobinsonCheva... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:LienY... | lld:pubmed |
| pubmed-article:16950982 | pubmed:author | pubmed-author:TimmonsMargar... | lld:pubmed |
| pubmed-article:16950982 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16950982 | pubmed:volume | 118 | lld:pubmed |
| pubmed-article:16950982 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16950982 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16950982 | pubmed:pagination | 924-32 | lld:pubmed |
| pubmed-article:16950982 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:meshHeading | pubmed-meshheading:16950982... | lld:pubmed |
| pubmed-article:16950982 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16950982 | pubmed:articleTitle | Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. | lld:pubmed |
| pubmed-article:16950982 | pubmed:affiliation | Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1260, USA. | lld:pubmed |
| pubmed-article:16950982 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16950982 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16950982 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16950982 | lld:pubmed |
